Filter
106
Filtered Results: 106
Text search:
Multidisciplinary
Collaborative
Group
for
the
Scientific
Monitoring
of
COVID-19
(GCMSC)
Featured
Recommendations
13
New Publications
47
Language
Document type
Studies & Reports
45
Strategic & Response Plan
25
Guidelines
19
Manuals
14
No document type
2
Training Material
1
Countries / Regions
Global
12
Africa
5
Western and Central Europe
3
Brazil
3
Peru
2
Latin America and the Carribbean
2
West and Central Africa
2
Western Pacific Region
2
Eastern Europe and Central Asia
2
East and Southern Africa
2
Colombia
1
Timor Leste/ East Timor
1
Kenya
1
Ukraine
1
Chile
1
Venezuela
1
Germany
1
Middle East and North Africa
1
South–East Asia Region
1
Bolivia
1
Argentina
1
Russia
1
Authors & Publishers
Publication Years
Category
COVID-19
8
Studies & Reports
6
Policies
5
Disaster Preparedness
4
Infection Control & Prevention (IPC)
3
Communicable Diseases
2
Palliative Care
2
Virology
2
Health System Strengthening
2
Guidelines
2
Palliative Care
2
Disease Prevention & Control
2
Pharmacy & Technology
1
Monitoring & Evaluation
1
Cervical Cancer
1
Nutrition
1
NCD
1
Child protection
1
Community Health
1
Capacity Building
1
Humanitarian Crisis
1
Mental Health
1
Other
1
Respiratory Infections
1
Surgery & Anaesthesia
1
Health Systems
1
Protection & Security
1
NTDs & Others
1
Non-communicable Diseases
1
Laboratory Quality Assurance
1
Reproductive Health
1
Global Health
1
Toolboxes
Clinical Guidelines
8
Appeals and Response Plans
6
General documents One Health
5
IPC
4
Public Health
4
Country specific documents
4
Hospital Readiness/Essential Health Services
4
One Health
4
Laboratory Guidance
3
Substance Use Disorders, Others
3
Training
3
Prevention & Preparedness
3
Diagnostics & Laboratory Guidance
3
Global Impact: Socio-economic, health services, TB & HIV
3
Long COVID/ Post-COVID Syndrome
3
Climate Change General
3
General
2
Infection Control General
2
Educational Settings
2
Access & Strategy
2
Immunization Guidelines
2
Genomic sequencing
2
Studies & Reports
2
Reports
2
Pharmacovigilance
2
Strategies & Roadmaps
2
General Information & Methodology
2
Asia
2
Disaster Preparedness & Prevention
2
Capacity Building
2
Drugs
1
Surveillance
1
Policies & Strategies
1
Prevention & Control
1
Influenza Prevention & Control
1
Policies & Programmes
1
Influenza
1
General Studies & Reports
1
Workplace
1
Stress
1
International
1
Climate & Health
1
Situation Reports & Updates
1
Best Practice
1
Studies
1
Infection Prevention & Hygiene
1
Context & Facts, Travel Advice
1
Risk Communication & Community Engagement
1
Surveillance & Contact tracing
1
Covid-19 & the One Health Approach
1
Covid-19 & Climate Change
1
For Parents & Children
1
For Health Worker
1
Gender Aspects
1
Medical & Community Masks
1
Infection Control & Prevention (IPC)
1
Essential Medicines & Medical Devices
1
Tips & Best Practice Examples
1
Logistics & Supply
1
SARS-CoV-2 Variants
1
Others
1
Others
1
Health Promotion
1
Midwives
1
Nurses
1
Palliative Care
1
Advocacy
1
Overview & reports
1
Rational use of Medicine
1
Resuscitation
1
Surgery
1
Guiding documents and principles
1
Agriculture incl. animal husbandry
1
Antimicrobial Resistance (AMR)
1
Non-communicable Diseases NCD
1
Education Principles
1
Health Impact & Climate Change
1
Humanitarian Aid Guidelines
1
Waste management
1
Patient Safety
1
NTDs General
1
Health Worker
1
Health Financing Toolbox
1
Women
1
Community Worker
1
Assessment & Response
1
Health Policy & the Global Health Landscape
1
HIV service delivery
1
Depression
1
Global Health Action
1
Studies & Reports
1
Food & Nutrition
1
COVID-19 has turned the world upside down. Everything has been impacted. How we live and interact with each other, how we work and communicate, how we move around and travel. Every aspect of our lives has been affected.
The report underscores that sexual and reproductive health and rights are often the first to be sacrificed during epidemics and that the gains of the past decade must be protected. The report also makes it clear that scarce resources must be focused on the most marginalized women and girls, includin...
WHO published the first COVID-19 Strategic Response and Preparedness Plan (SPRP) on 3 February, 2020. This report highlights the main points of progress that were made up to 30 June 2020 under the three objectives outlined in the SPRP: scaling up international coordination and support; scaling up co...
8 January 2021
Sequencing enabled the world to rapidly identify SARS-CoV-2 and develop diagnostic tests and other tools for outbreak management. Continued genome sequencing supports the monitoring of the disease’s spread and evolution of the virus. Accelerated integration of genome sequencing int...
22 December 2020
The COVID-19 vaccine safety guidance manual has been developed upon recommendation and guidance of GACVS members, as well as by experts incorporating current and available information critical to all stakeholders when COVID-19 vaccines will be introduced.
For ease of use, the man...
17 February 2021
During the second joint meeting of African ministers responsible for health, ICT and transport on the rollout of the Africa Against COVID-19: Saving Lives, Economies and Livelihoods campaign, a call was made to African countries to work together towards harmonizing travel entry and...
WHO Living guideline: Drugs to prevent COVID-19
recommended
Interim guidance 2 march 2021
Current use of drugs to prevent COVID-19 is variable, reflecting large-scale uncertainty. Numerous randomized trials of many different drugs are underway to inform practice. This first version of the Drugs to prevent COVID-19: A WHO living guideline contains new inform...
n light of the potential risk posed by SARS-CoV-2 variants, in January 2021 WHO organized an ad hoc consultation to discuss the development of an R&D agenda in response to existing and emerging SARS-CoV-2 variants.
The key objectives were to identify the critical research questions related to var...
History has shown that governments tend to deprioritize environmental commitments during times of financial and public crises as they work to mitigate immediate needs—and the age of COVID-19 has been no different. Even though human interaction with wildlife is believed to be the cause of the pande...
Working towards better COVID-19 outcomes in the WHO European Region.From the first COVID-19 cases in Europe reported on
24 January 2020, the pandemic reached 1 million cases
within 3 months, 10 million cases within 8 months, and
100 million cases in Europe alone within 2 years. Over
the course o...
The Lancet Regional health Americas, vol.10 (2022) June 1, March 04, 2022DOI:https://doi.org/10.1016/j.lana.2022.100222
Despite its rich culture, great economic potential, high level of education and last but not least its sheer size – it is the largest state whose borders lie entirely within Europe and is 1.7 times the size of the Federal Republic of Germany – Ukraine seems far away in perception and awareness. ...
Addressing comorbidities and risk factors for TB is a crucial component of Pillar one of the End TB Strategy, which focuses on integrated patient-centred care and prevention, including action on TB and comorbidities. The Framework for collaborative action on TB and comorbidities aims to support coun...
This collection of case studies on risk communication and community engagement (RCCE) from 18 different country/area level public health partners in the WHO European Region provides evidence of numerous results achieved and lessons learned since the start of the COVID-19 pandemic. RCCE has not...
WHO needs US$2.54 billion to provide life-saving assistance to millions of people around the world facing health emergencies. WHO’s Health Emergency Appeal is a consolidation of WHO’s priorities and financial requirements for 2023 to carry out health interventions in emergency and humanitarian r...
The WHO Living guideline: Drugs to prevent COVID-19 contains the Organization’s most up-to-date recommendations for the use of drugs to prevent COVID-19. The latest version of this living guideline is available in pdf format (via the ‘Download’ button) and via an online platform.
Guidelines ...
It is impossible to address the many complex needs of respiratory virus surveillance with a single surveillance system. Multiple systems, investigations and studies must each be fit-for-purpose to specific priority surveillance objectives, and only together can they provide essential information to ...
The Pandemic Influenza Pandemic (PIP) Framework's Partnership Contribution (PC) High-Level Implementation Plan III (HLIP III) outlines the strategy for strengthening global pandemic influenza preparedness from 2024 to 2030. HLIP III takes into consideration the lessons learned from the response to t...
This checklist is for any organization or person supporting the routine use of evidence in
the process of policy-making. Evidence-informed policy-making (EIPM) is essential for achieving the Sustainable Development Goals (SDGs) and universal health coverage (UHC). Its importance is emphasized in WH...
While there has been real progress in addressing the burden of disease in the WHO African region, the COVID-19 pandemic has highlighted the link between health, economics and security, as the region saw decades of progress threatened, including positive trends in decreasing inequality. In the Africa...
